Resmed (RSMDF) Other Operating Expenses (2009 - 2026)

Resmed (RSMDF) has reported Other Operating Expenses for 18 consecutive years, with $10.5 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Other Operating Expenses fell 11.98% year-over-year to $10.5 million; the trailing twelve-month figure through Jun 2026 stood at $45.5 million (changed 0.42% YoY), and the FY2026 full-year result was -$57.5 million, changed N/A from the prior year.
• Other Operating Expenses eased to $10.5 million in Q2 2026 per RSMDF's latest filing, from $11.2 million in the prior quarter.
• Across five years, Other Operating Expenses topped out at $21.5 million in Q2 2023 and bottomed at $7.7 million in Q1 2022.
• Historically, Other Operating Expenses has averaged $11.3 million across 5 years, with a median of $11.3 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Other Operating Expenses jumped 173.24% in 2023, then slumped 47.61% in 2024.
• Over 5 years, Other Operating Expenses stood at $9.6 million in 2022, then gained by 21.06% to $11.6 million in 2023, then fell by 4.58% to $11.0 million in 2024, then rose by 6.49% to $11.8 million in 2025, then dropped by 10.75% to $10.5 million in 2026.
• According to Business Quant data, Other Operating Expenses over the past three periods registered $10.5 million, $11.2 million, and $11.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.